Table 4.
Provider survey responses to questions regarding their experiences with the Genomic Prescribing System (GPS).
| Survey Responses for Providers Who Logged into GPS | |||||
| Agree Strongly N (%) | Agree Somewhat N (%) | Not Sure N (%) | Disagree Somewhat N (%) | Disagree Strongly N (%) | |
| The GPS information was relevant to my patient’s situation. | 1 (6%) | 4 (24%) | 4 (24%) | 5 (29%) | 3 (18%) |
| I decreased the risk of side effects for my patients by utilizing GPS information. | 0 (0%) | 4 (24%) | 5 (29%) | 2 (12%) | 6 (35%) |
| Accessing the GPS was a natural part of my clinical workflow. | 1 (6%) | 4 (24%) | 3 (18%) | 6 (35%) | 3 (18%) |
| I had enough time to evaluate the results presented in GPS. | 5 (29%) | 7 (41%) | 3 (18%) | 1 (6%) | 1 (6%) |
| The GPS provided straightforward prescribing guidance. | 4 (24%) | 7 (41%) | 5 (29%) | 1 (6%) | 0 (0%) |
| The GPS was simple to use. | 5 (29%) | 8 (47%) | 3 (18%) | 1 (6%) | 0 (0%) |
| The clinical decision support summaries were too complicated or technical. | 0 (0%) | 0 (0%) | 1 (6%) | 7 (41%) | 9 (53%) |
| Survey Responses for Providers Who Did Not Log into GPS | |||||
| Agree Strongly N (%) | Agree Somewhat N (%) | Not Sure N (%) | Disagree Somewhat N (%) | Disagree Strongly N (%) | |
| I did not have time to log into the GPS. | 4 (33%) | 1 (8%) | 2 (17%) | 1 (8%) | 4 (33%) |
| I did not log into the GPS due to the complexity of this particular patient. | 1 (8%) | 0 (0%) | 0 (0%) | 3 (25%) | 8 (67%) |
| I did not remember this patient was in the study. | 4 (33%) | 3 (25%) | 0 (0%) | 3 (25%) | 2 (17%) |
| I did not remember how to access the GPS. | 2 (17%) | 5 (42%) | 1 (8%) | 1 (8%) | 3 (25%) |
| I have not found the GPS to be a useful tool in my practice because the information provided is typically not clinically relevant. | 1 (8%) | 1 (8%) | 7 (58%) | 2 (17%) | 1 (8%) |
| I have not found the GPS to be a useful tool in my practice because the information provided is typically not supported by enough evidence. | 1 (8%) | 0 (0%) | 8 (67%) | 1 (8%) | 2 (17%) |
| I have not found the GPS to be a useful tool in my practice because I have not been able to adapt the system to fit my needs. | 1 (8%) | 3 (25%) | 5 (42%) | 2 (17%) | 1 (8%) |
| For this patient, I did not think there would be an obvious benefit from incorporating genetic information. | 0 (0%) | 2 (17%) | 7 (58%) | 2 (17%) | 1 (8%) |
| Changing the drug or dose would have meant deviating from the accepted standard of care, so pharmacogenomic information was not relevant to my decision-making. | 0 (0%) | 1 (8%) | 3 (25%) | 5 (42%) | 3 (25%) |